Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Androgen Receptor Regulates CD44 Expression in Bladder Cancer
Joseph L. Sottnik, Lauren A. Vanderlinden, Molishree Joshi, et al.
Cancer Research (2021) Vol. 81, Iss. 11, pp. 2833-2846
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Bladder cancer
Lars Dyrskjøt, Donna E. Hansel, Jason A. Efstathiou, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 170
Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021
Hao Zi, Mengyang Liu, Li Luo, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 23
The androgen receptor in bladder cancer
Jinbo Chen, Chi‐Ping Huang, Chao Quan, et al.
Nature Reviews Urology (2023) Vol. 20, Iss. 9, pp. 560-574
Closed Access | Times Cited: 26
Sex-biased adaptive immune regulation in cancer development and therapy
Johanna M. Schafer, Tong Xiao, Hyunwoo Kwon, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104717-104717
Open Access | Times Cited: 23
Strategies for High-Efficiency Mutation Using the CRISPR/Cas System
Shuying Feng, Zilong Wang, Aifang Li, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 21
Sexual dimorphism in bladder cancer: a review of etiology, biology, diagnosis, and outcomes
Sheng Zhu, Huasheng Zhao
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 4
CD44 and Its Role in Solid Cancers – A Review: From Tumor Progression to Prognosis and Targeted Therapy
João Martins Gama, Rui Caetano Oliveira
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
An Integrated Bioinformatics Analysis towards the Identification of Diagnostic, Prognostic, and Predictive Key Biomarkers for Urinary Bladder Cancer
Michail Sarafidis, George Ι. Lambrou, Vassilis Zoumpourlis, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3358-3358
Open Access | Times Cited: 18
Sulforaphane Impact on Reactive Oxygen Species (ROS) in Bladder Carcinoma
Hui Xie, Felix K.‐H. Chun, Jochen Rutz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5938-5938
Open Access | Times Cited: 23
Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective
Yongquan Tang, Yan Chen, Zhe Zhang, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2116-2116
Open Access | Times Cited: 18
Sex differences in bladder cancer: emerging data and call to action
Dan Theodorescu, Zihai Li, Xue Li
Nature Reviews Urology (2022) Vol. 19, Iss. 8, pp. 447-449
Open Access | Times Cited: 13
CD44 potentiates hepatocellular carcinoma migration and extrahepatic metastases via the AKT/ERK signaling CXCR4 axis
Peiyi Xie, Jiuliang Yan, Mengyuan Wu, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 12, pp. 689-689
Open Access | Times Cited: 13
A dual-responsive electrochemical biosensor based on artificial protein imprinted polymers and natural hyaluronic acid for sensitive recognition towards biomarker CD44
Min Cui, Xiaofeng Sun, Rui Liu, et al.
Sensors and Actuators B Chemical (2022) Vol. 371, pp. 132554-132554
Closed Access | Times Cited: 13
Small Cajal Body-Specific RNA12 Promotes Carcinogenesis through Modulating Extracellular Matrix Signaling in Bladder Cancer
Qinchen Lu, Jiandong Wang, Yuting Tao, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 483-483
Open Access | Times Cited: 2
Roles of Androgen Receptor Signaling in Urothelial Carcinoma
Debasish Sundi, Katharine A. Collier, Yuanquan Yang, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 746-746
Open Access | Times Cited: 2
Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer
Shruti D. Shah, Bryan M. Gillard, Michelle Wrobel, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer
Javier Leo, Eleonora Dondossola, Kaitlin J. Basham, et al.
Endocrinology (2023) Vol. 164, Iss. 6
Closed Access | Times Cited: 6
CD24: A Marker for an Extended Expansion Potential of Urothelial Cancer Cell Organoids In Vitro?
Ruizhi Geng, Niklas Harland, Ivonne A. Montes‐Mojarro, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5453-5453
Open Access | Times Cited: 9
Apoptosis-inducing Plant-based Phenolic Compounds are Effective on Leukemia Cell Lines
Amin Soltani, Milad Shahini Shams Abadi, Mohammad Raeisi, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 14, pp. 1092-1104
Closed Access | Times Cited: 5
Mechanism of Sex Differences in Bladder Cancer: Evident and Elusive Sex-biasing Factors
Christa M. Lam, Zihai Li, Dan Theodorescu, et al.
Bladder Cancer (2022) Vol. 8, Iss. 3, pp. 241-254
Open Access | Times Cited: 8
CD44 in Bladder Cancer
Jason E. Duex, Dan Theodorescu
Cancers (2024) Vol. 16, Iss. 6, pp. 1195-1195
Open Access | Times Cited: 1
Are androgen receptor agonists a treatment option in bladder cancer?
Michael L. De Ieso, Ahmed Faris Aldoghachi, Wayne D. Tilley, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2024), pp. 106623-106623
Open Access | Times Cited: 1
Androgen receptor signalling in non-prostatic malignancies: challenges and opportunities
G. Paolo Dotto, An Buckinx, Berna C. Özdemir, et al.
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 1
Genetically supported causality between benign prostate hyperplasia and urinary bladder neoplasms: A mendelian randomization study
Wenzhi Du, Tianyi Wang, Wenxiu Zhang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 5
Gender Differences in Urothelial Bladder Cancer: Effects of Natural Killer Lymphocyte Immunity
Charles T. Lutz, Lydia Livas, Steven R. Presnell, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 21, pp. 5163-5163
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top